1. Home
  2. TBLA vs FTRE Comparison

TBLA vs FTRE Comparison

Compare TBLA & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$4.95

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$19.12

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
FTRE
Founded
2007
1996
Country
United States
United States
Employees
2000
N/A
Industry
Computer Software: Programming Data Processing
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
TBLA
FTRE
Price
$4.95
$19.12
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$5.00
$14.06
AVG Volume (30 Days)
2.7M
1.1M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
$7.63
N/A
Revenue Next Year
$5.25
$3.09
P/E Ratio
$42.36
N/A
Revenue Growth
N/A
1.00
52 Week Low
$2.84
$5.27
52 Week High
$5.71
$20.19

Technical Indicators

Market Signals
Indicator
TBLA
FTRE
Relative Strength Index (RSI) 46.31 72.87
Support Level $3.94 $9.10
Resistance Level $5.18 N/A
Average True Range (ATR) 0.18 0.75
MACD -0.09 0.10
Stochastic Oscillator 24.46 81.16

Price Performance

Historical Comparison
TBLA
FTRE

About TBLA Taboola.com Ltd.

Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: